Skip to main content
OpenTrials

Clinical trial condition

Urothelial Cancer

Explore clinical trials studying Urothelial Cancer. Study availability and eligibility vary by location and protocol.

54 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Cancer trial results

Completed

Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer

NCT05219435

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • Hospital Universitario Juan Ramón Jiménez Huelva, Andalusia, Spain
  • Hospital Universitario Virgen de la Macarena Seville, Andalusia, Spain
  • Hospital Clínico Universitario de Zaragoza Zaragoza, Aragon, Spain
  • Hospital Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain
View Trial Details
Completed

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

NCT03474107

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • UCI Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Sacramento, California, United States
  • Innovative Clinical Research Whittier, California, United States
  • University of Colorado Denver, Colorado, United States
View all 158 locations
View Trial Details
Completed

A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

NCT05366725

Conditions
Urothelial Cancer
Locations
  • University Hospitals Bristol Bristol, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Royal Surrey County Hospital Guildford, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Completed

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

NCT05259696

Conditions
Adnexal Diseases, Bladder Cancer, Breast Cancer, +68 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Health Care Stanford, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Completed

Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer.

NCT03406650

Conditions
Neoplasms, Urothelial Cancer
Locations
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
  • Urologische Universitätsklinik Essen Essen, Germany
  • Kantonspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
View all 17 locations
View Trial Details
Completed

A Study of TAS-120 in Patients With Advanced Solid Tumors

NCT02052778

Conditions
Adenocarcinoma, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors, Breast Cancer, +19 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic (AZ) Scottsdale, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 58 locations
View Trial Details

Related conditions